Andrea Pisesky | Congenital Heart Defects | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Andrea Pisesky
Stollery Children’s Hospital

Andrea Pisesky
Affiliation Stollery Children’s Hospital
Country Canada
Scopus ID 57219721692
Documents 9
Citations 478
h-index 7
Subject Area Congenital Heart Defects
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0003-0094-0193

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada, with a documented research profile associated with congenital heart defects and cardiovascular medicine. The supplied bibliometric information records nine documents, 478 citations, and an h-index of 7. The profile also includes ORCID identifier 0000-0003-0094-0193, supporting persistent researcher identification. [1] [2]

Abstract

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada whose documented scholarly profile focuses on congenital heart defects and cardiovascular medicine. The supplied bibliometric record identifies nine documents, 478 citations, and an h-index of 7 under Scopus author identifier 57219721692. These indicators provide a quantitative representation of documented research activity and citation visibility. The profile is additionally associated with ORCID identifier 0000-0003-0094-0193, supporting researcher identification and record disambiguation. This article presents the available academic information in a structured recognition profile, covering research orientation, contributions, publications, citation impact, and relevance to consideration for a Best Researcher Award within cardiovascular medicine.

Keywords

Andrea Pisesky, Best Researcher Award, congenital heart defects, cardiology, cardiovascular medicine, Stollery Children’s Hospital, Canada, Scopus, ORCID, research impact. [1] [2]

Introduction

Congenital heart defects are an important area of cardiovascular research because structural abnormalities of the heart and major vessels can require continuing clinical assessment and multidisciplinary management. Research in this field encompasses diagnosis, intervention, outcomes, epidemiology, and long-term care. Bibliographic databases such as Scopus provide standardized indicators that can assist in describing documented scholarly activity and citation performance. [1] [5]

Research Profile

The supplied profile places Andrea Pisesky within the research area of congenital heart defects and cardiovascular medicine, with an institutional affiliation at Stollery Children’s Hospital in Canada. The reported Scopus record contains nine documents, 478 citations, and an h-index of 7. ORCID identifier 0000-0003-0094-0193 provides an additional persistent identifier for researcher disambiguation. [1] [2]

Research Contributions

The documented subject focus is relevant to congenital cardiac conditions and cardiovascular medicine, disciplines that rely on clinical investigation, patient characterization, treatment evaluation, outcomes research, and interdisciplinary collaboration. Based on the supplied information, the research profile can be described within this broad domain without attributing specific scientific findings that are not independently established by the available publication record. [3]

Publications

The supplied Scopus information records nine documents associated with author identifier 57219721692. These documents constitute the reported scholarly output underlying the stated citation count and h-index. Publication-level details such as article titles, journals, dates, authorship, and DOI identifiers should be verified against the relevant bibliographic records before being used for detailed assessment. [1]

Research Impact

The reported bibliometric profile contains 478 citations and an h-index of 7. These measures provide quantitative indicators of citation activity associated with the supplied author record. Citation counts are dynamic and may change as databases are updated; consequently, bibliometric indicators should be considered alongside publication quality, research relevance, methodological contribution, and broader academic or clinical influence. [1]

Award Suitability

The available academic indicators provide relevant evidence for consideration within a researcher recognition framework focused on cardiology and cardiovascular medicine. The combination of documented scholarly output, citation activity, subject-area relevance, institutional affiliation, and persistent researcher identification can support an evidence-based nomination. Final eligibility and recognition should be determined according to the official criteria and review procedures of the organizing body. [4]

Conclusion

Andrea Pisesky’s supplied academic profile reflects research activity associated with congenital heart defects and cardiovascular medicine in Canada. The reported Scopus indicators of nine documents, 478 citations, and an h-index of 7 provide measurable evidence of documented scholarly visibility. Together with ORCID identification and institutional affiliation, these indicators form a structured basis for an academic recognition profile while remaining subject to independent verification and formal award evaluation.

References

  1. Elsevier. (n.d.). Scopus author details: Andrea Pisesky, Author ID 57219721692. Scopus.
    https://www.scopus.com/pages/authors/57219721692
  2. ORCID. (n.d.). ORCID record: Andrea Pisesky. ORCID.
    https://orcid.org/0000-0003-0094-0193
  3. Journal article(2021.). Adverse fibrosis remodeling and aortopulmonary collateral flow are associated with poor Fontan outcomes.
    https://doi.org/10.1186/s12968-021-00782-9
  4. Journal article(2021.). Cardiology and Cardiovascular Medicine. Standardisation of management after Norwood operation has not improved 1-year outcomes.
    https://doi.org/10.1017/S1047951120003376
  5. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt
Radwa Mehanna
Affiliation Alexandria University
Country Egypt
Scopus ID 55851530300
Documents 43
Citations 927
h-index 19
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

References

  1. Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
    https://esev-eg.org/board/
  2. Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
    https://doi.org/10.4252/wjsc.v14.i1.1
  3. Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
    https://doi.org/10.1186/s40659-025-00593-7
  4. Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
    https://doi.org/10.1093/eurheartj/suab069.019
  5. Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
    https://doi.org/10.1016/j.vph.2023.107223